DNA shuffling technology was used to create a candidate PCV2 vaccine containing genetic signatures of multiple PCV2 subtypes.
The shuffled chimeric virus vaccine candidate is viable and induced anti-PCV2 neutralizing antibodies in pigs.
The candidate PCV2 vaccine is capable of protecting against the predominant PCV2b subtype and the emerging PCV2d strain.